Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Zai Lab
Zai Lab
(ZLAB)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Amrubicin
small cell lung carcinoma
Globulin, immune
multiple myeloma
,
b-cell chronic lymphocytic leukemia
,
plasma cell neoplasms
,
pharmacokinetics
,
pancreatic neoplasms
,
adenocarcinoma
,
hodgkin disease
,
neoplasms
,
glioblastoma
,
infections
,
hepatitis c
,
chronic hepatitis c
,
hepatitis
,
chronic hepatitis
,
hepatitis a
,
carcinoma
,
hepatocellular carcinoma
,
pulmonary eosinophilia
,
eosinophilia
,
breast neoplasms
,
mucinous adenocarcinoma
,
ductal carcinoma breast
,
inflammatory breast neoplasms
,
lymphoma
,
postmenopausal osteoporosis
,
non-hodgkin lymphoma
,
mantle-cell lymphoma
,
chronic urticaria
,
asthma
,
multiple sclerosis
,
sclerosis
Histone-arginine methyltransferase carm1
cholestasis
,
pruritus
,
pregnancy complications
,
intrahepatic cholestasis
,
sclerosing cholangitis
,
biliary liver cirrhosis
,
digestive system diseases
,
cholangitis
,
fragile x syndrome
Surlorian
psoriasis
,
small cell lung carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use